Covered recipient · General Payments record
ANASTASIA D CLEARY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,291.05
- Reported across 253 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $272.24 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $133.01 | 10 |
| Lilly USA, LLC | $32.99 | 2 |
| Novo Nordisk AS | $32.72 | 2 |
| Otsuka America Pharmaceutical, Inc. | $30.95 | 2 |
| Lundbeck LLC | $15.64 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.73 | 1 |
| Acerta Pharma LLC | $13.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $12.60 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117225514 | CMS |
| Amgen Inc. | $17.64 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111551300 | CMS |
| Amgen Inc. | $11.00 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117225516 | CMS |
| Amgen Inc. | $13.48 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117225518 | CMS |
| Amgen Inc. | $6.92 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117225520 | CMS |
| Amgen Inc. | $14.12 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117225522 | CMS |
| Amgen Inc. | $17.11 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111551302 | CMS |
| Amgen Inc. | $16.69 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117225524 | CMS |
| Amgen Inc. | $18.97 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117225526 | CMS |
| Amgen Inc. | $4.48 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111551304 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.20 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105685041 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.73 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117867354 | CMS |
| Lilly USA, LLC | $18.24 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135998243 | CMS |
| Lilly USA, LLC | $14.75 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136046955 | CMS |
| Lundbeck LLC | $15.64 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145905685 | CMS |
| Novo Nordisk Inc | $14.48 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097265321 | CMS |
| Novo Nordisk Inc | $18.24 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097526152 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.76 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118877354 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.19 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118877356 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.